Hot Medical Stocks To Buy For 2019


Image source: Getty Images.

What happened

Shares of Insulet Corporation(NASDAQ:PODD), a medical device company primarily focused on diabetes,rose by as much as 11% in afternoon trading on Friday.

So what

The drug delivery specialist didn’t release any news on Friday that could justify its big move.Instead, Insulet’s stock appears to be rising in response to goodnews that was released by one of the company’s partners.

DexCom (NASDAQ:DXCM), a diabetes-focused company that makes continuous glucose monitors, announced on Thursday evening that theCenters for Medicare & Medicaid Services (CMS) has officially decided to cover its G5 Mobilesystem.

DexCom’s CEO Kevin Sayer was thrilled with the news, stating, “This landmark CMS Ruling will make available the most important technology in diabetes management to theMedicarepopulation.”

Hot Medical Stocks To Buy For 2019: Trinity Industries Inc.(TRN)


Advisors’ Opinion:

  • [By Craig Jones]

    On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about high options activity in Trinity Industries Inc (NYSE: TRN).

    He said that options traders bought 5,200 contracts of the January 36 calls for $1.15 in the first half of the trading session. The trade breaks even at $37.15 or 3.17 percent above the closing price Monday. Najarian believes the stock is going to break out on the upside and he decided to follow the trade and buy the January calls. He is going to hold the position for two weeks.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

  • [By ]

    5. Trinity Industries (NYSE: TRN)
    This industrial company is trading lower by over 15% in 2018. A substantial shareholder named Valueact Holdings has purchased over one million shares in the $32.00 range.

  • [By Jon C. Ogg]

    Also seen aswinners are equipment and fixtures makers, from construction to rail to transports. Trinity Industries Inc. (NYSE: TRN), largely considered a rail winner, was up 1.4% at $27.20 late on Monday.

Hot Medical Stocks To Buy For 2019: PDC Energy, Inc.(PDCE)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Goldman Sachs analyst Brian Singer and team contend that EOG Resources (EOG), Diamondback Energy (FANG), PDC Energy (PDCE), Pioneer Natural Resources (PXD), and RSP Permian (RSPP) can benefit from greater productivity. They explain:

  • [By Ben Levisohn]

    Names which screen well on a combination of attractive valuation and equitized capital structure, include Outperform rated Apache, Anadarko Petroleum,Gulfport Energy as well as Market Perform rated QEP Resources (QEP) and PDC Energy (PDCE).

Hot Medical Stocks To Buy For 2019: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.


    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

Leave a Reply

Your email address will not be published.